We are live on ! Find out more
AMPH icon

Amphastar Pharmaceuticals
AMPH

134 hedge funds and large institutions have $478M invested in Amphastar Pharmaceuticals in 2019 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 47 increasing their positions, 50 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

13% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 15

3.57% more ownership

Funds ownership: 47.43% → 51% (+3.6%)

1% more capital invested

Capital invested by funds: $471M → $478M (+$6.53M)

1% more funds holding

Funds holding: 133 → 134 (+1)

6% less repeat investments, than reductions

Existing positions increased: 47 | Existing positions reduced: 50

96% less call options, than puts

Call options by funds: $19K | Put options by funds: $496K

Holders
134
Holders Change
+1
Holders Change %
+0.75%
% of All Funds
2.94%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
17
Increased
47
Reduced
50
Closed
15
Calls
$19K
Puts
$496K
Net Calls
-$477K
Net Calls Change
+$19K

Top Buyers

1
VOYA Investment Management
VOYA Investment Management
Georgia
+$12.2M
2
Marshall Wace
Marshall Wace
United Kingdom
+$8.61M
3
Invesco
Invesco
Georgia
+$8.23M
4
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
+$5.99M
5
SAM
Silvercrest Asset Management
New York
+$4.81M

Top Sellers

1
N
Nuveen
North Carolina
-$5.65M
2
ACM
Argent Capital Management
Missouri
-$3.97M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
-$3.43M
4
Allianz Asset Management
Allianz Asset Management
Germany
-$1.61M
5
Canada Life
Canada Life
Manitoba, Canada
-$979K
Name Holding Trade Value Shares
Change 		Change in
Stake
BlackRock
1
BlackRock
New York
$119M +$1.43M +68,683 +1%
Vanguard Group
2
Vanguard Group
Pennsylvania
$48.1M +$924K +44,367 +2%
Dimensional Fund Advisors
3
Dimensional Fund Advisors
Texas
$35.8M -$305K -14,620 -0.8%
Federated Hermes
4
Federated Hermes
Pennsylvania
$34.7M +$2.5M +120,018 +7%
State Street
5
State Street
Massachusetts
$21.2M -$499K -23,943 -2%
Renaissance Technologies
6
Renaissance Technologies
New York
$14.5M +$2.97M +142,700 +24%
Invesco
7
Invesco
Georgia
$13.4M +$8.23M +395,073 +141%
VOYA Investment Management
8
VOYA Investment Management
Georgia
$12M +$12.2M +587,627 +3,731%
Northern Trust
9
Northern Trust
Illinois
$10.6M +$1.1M +52,653 +11%
Geode Capital Management
10
Geode Capital Management
Massachusetts
$9.76M +$163K +7,809 +2%
Arrowstreet Capital
11
Arrowstreet Capital
Massachusetts
$9M +$5.99M +287,533 +173%
Marshall Wace
12
Marshall Wace
United Kingdom
$8.2M +$8.61M +413,293 New
Bank of New York Mellon
13
Bank of New York Mellon
New York
$7.6M -$137K -6,577 -2%
RCAMU
14
Rothschild & Co Asset Management US
Connecticut
$6.89M -$4.5K -216 -0.1%
Ameriprise
15
Ameriprise
Minnesota
$6.33M +$2.65M +127,423 +67%
N
16
Nuveen
North Carolina
$6.02M -$5.65M -271,412 -47%
UBS AM
17
UBS AM
Illinois
$5.78M +$8.77K +421 +0.1%
Principal Financial Group
18
Principal Financial Group
Iowa
$5.6M -$219K -10,498 -4%
Nordea Investment Management
19
Nordea Investment Management
Sweden
$5.09M +$143K +6,853 +3%
SAM
20
Silvercrest Asset Management
New York
$4.58M +$4.81M +231,041 New
MCM
21
Matarin Capital Management
New York
$4.43M -$282K -13,560 -6%
MAM
22
Martingale Asset Management
Massachusetts
$4.25M +$285K +13,706 +7%
Charles Schwab
23
Charles Schwab
California
$4.21M +$562 +27 +0%
Goldman Sachs
24
Goldman Sachs
New York
$4.19M +$3.41M +163,585 +343%
Jacobs Levy Equity Management
25
Jacobs Levy Equity Management
New Jersey
$3.52M +$2.27M +109,189 +160%
1
2 3 4 5

AMPH Hedge Fund Activity: Q3 2019 in Review

134 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Amphastar Pharmaceuticals (AMPH) for Q3 2019, worth a combined $478M — up 1.4% from $471M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new AMPH positions and 15 closed out — a net gain of 2 holders — while 47 added to existing stakes and 50 trimmed.

The largest buyer was VOYA Investment Management, adding an estimated $12.2M. The largest seller was Nuveen, cutting an estimated $5.65M.

  • 134 institutional investors held Amphastar Pharmaceuticals (AMPH) as of Q3 2019, up from 133 in Q2 2019.
  • Funds reported $478M of Amphastar Pharmaceuticals stock for Q3 2019, up 1.4% quarter-over-quarter.
  • 17 funds opened new Amphastar Pharmaceuticals positions in Q3 2019 and 15 closed out, a net change of +2 holders.
  • The largest Amphastar Pharmaceuticals buyer in Q3 2019 was VOYA Investment Management, an estimated $12.2M added.
  • The largest Amphastar Pharmaceuticals seller in Q3 2019 was Nuveen, an estimated $5.65M sold.

Based on aggregated 13F filings for Q3 2019.